Modified form of chemotherapy before and after surgery enhances survival in pancreatic cancer patients

FHS
June 20, 2024
6:31 pm

Patients with pancreatic cancer who received chemotherapy both before and after surgery experienced longer survival rates than would be expected from surgery followed by chemotherapy, according to a new study from researchers at Yale Cancer Center (YCC) and Yale School of Medicine.

Systemic barriers hold back diverse talent in academic medicine

A JAMA Network Open study reveals persistent inequities in academic medicine, where women and racial/ethnic minority physicians face significant barriers to promotions. These disparities, rooted

December 2, 2024

Closing the gap: PATROL’s approach to overcoming lung cancer diagnostic inequality

A non-invasive, low-cost lung cancer detection platform called PATROL.

January 9, 2024

Biogen ends agreement with Acorda for multiple sclerosis drug Fampyra

Biogen is handing back ex-US commercialization rights to Acorda Therapeutics for the multiple sclerosis drug Fampyra. Acorda will have the drug in-house effective Jan. 1,

January 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.